Cleared Traditional

K832796 - STAR HCG MONOCLONAL ANTIBODY IMMUNORAD

K832796 is an FDA 510(k) clearance for STAR HCG MONOCLONAL ANTIBODY IMMUNORAD, manufactured by Syncor Intl. Corp.. The device is a Class 2 Chemistry device with product code JHI cleared through the Traditional 510(k) pathway after a 159-day FDA review.

K832796 · Syncor Intl. Corp. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1984
Decision
159d
Days
Class 2
Risk

K832796 is an FDA 510(k) clearance for the STAR HCG MONOCLONAL ANTIBODY IMMUNORAD. Classified as Visual, Pregnancy Hcg, Prescription Use (product code JHI), Class II - Special Controls.

Submitted by Syncor Intl. Corp. (Mchenry, US). The FDA issued a Cleared decision on January 24, 1984 after a review of 159 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1155 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Syncor Intl. Corp. devices

FDA 510(k) Submission Details - K832796

510(k) Number K832796 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 18, 1983
Decision Date January 24, 1984
Days to Decision 159 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
71d slower than avg
Panel avg: 88d · This submission: 159d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JHI Device Classification - Class 2, Special Controls

Product Code JHI Visual, Pregnancy Hcg, Prescription Use
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1155
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - JHI Visual, Pregnancy Hcg, Prescription Use

All 207
Devices cleared under the same product code (JHI) and FDA review panel - the closest regulatory comparables to K832796.
COATED TUBE HCG IMMUNOASSAY HCG
K841023 · Ventrex Laboratories, Inc. · May 1984
HCG RIA
K833851 · Syncor Intl. Corp. · Mar 1984
TANDEM VISUAL HCG IMMUNOENZYMETRIC
K834000 · Hybritech, Inc. · Feb 1984
TANDEM R-TOTAL B-GCG KIT
K833194 · Hybritech, Inc. · Jan 1984
OREIA II B-HCG, ENZYME INNUNOASSAY
K832801 · Organon, Inc. · Dec 1983
BHCG RIA KIT
K831264 · Micromedic Systems · Jun 1983